Digital Health & Care Congress 2016, King’s Fund, London

Digital Health & Care Congress 2016
Two-day congress | 5-6 July 2016 | The King’s Fund, London
The programme has been announced for The King’s Fund’s Digital Health and Care Congress 2016.                                             This year, key speakers will include:
·       Matthew Swindells, National Director, Commissioning Operations and Information, NHS England
·     Dame Fiona Caldicott, National Data Guardian, Health and Social Care
·     Mustafa Suleyman, Co-founder and Head of Applied Artificial Intelligence, Google DeepMind
·     Beverley Bryant, Director of Strategic Systems and Technology, NHS England
·     Rt Hon Jeremy Hunt, Secretary of State for Health
·     Dr Robert M. Wachter, Author of ‘The Digital Doctor’ and Professor and Interim Chairman, Department of Medicine,                                                         University of California, San Francisco.
NHS organisations are currently working to deliver the National Information Board’s Framework, Personalised Health and Care 2020. The aim is for 95 percent of GP patients to be offered e-consultations and other digital services; and 95 percent of tests to be digitally transferred between organisations by 2020. The annual Digital Health and Care Congress provides a key opportunity for you to join with peers to explore how the better use of technology and data can support and enable the key developments needed to transform outcomes for patients and citizens.
Find out more here

Promote your medical innovation with Personalize My Medicine!

Do you have a novel medical or healthcare innovation designed for patients and/or healthcare professionals that helps patients to take charge of their own health? Get in touch with us about our sponsorship packages with competitive pricing structures designed for all types and sizes of organizations engaged in medical innovation. You can email us at or use our Contact form.

Gene Editing

Yesterday’s announcement of the UK Human Fertilisation and Embryology Authority (HFEA)’s approval for genetically modifying human embryos marks a critical milestone in medical research. The research, which will be led by Dr Kathy Niakan at the Francis Crick Institute, focuses on studying how some of the genes that are active at the very early stages of embryonic development, can influence how embryonic stem cells differentiate into different types of cells and tissues, each having their specific functions. The studies proposed, aim to understand how particular abnormalities arising at these early stages can have an influence on infertility, miscarriage, and developmental disorders, and to identify potential therapeutic applications of stem cells. Balancing the highly contentious issues arising in both medicine and ethics is a truly tricky task. However, recent advances in gene editing have given hope to both patients and the many researchers working tirelessly to discover the molecular basis of genetic disorders and to develop treatments for over 7000 known rare diseases. Given that the majority of rare diseases can be attributed to a genetic defect and affect children, any technique that shows promise for ameliorating or preventing them is clearly of great interest to both the medical profession and patients alike.

Season’s Greetings!

Personalize My Medicine wishes you a very Merry Christmas and Happy New Year! Thank you to all our new followers, partners, collaborators, and supporters. We look forward to working with you in 2016!